ADVFN US – Market Content Editor
-

Tesla’s German Sales Plunge by Over 30% in May Despite Growth in EV Market
Tesla Inc. (NASDAQ:TSLA) experienced a sharp decline in vehicle sales in Germany during May, according to data released by the German Federal Motor Transport Authority (KBA). The electric car maker’s sales dropped by 36.2% compared to the same month last year, with just 1,210 units sold. Contrasting Tesla’s downturn, the German electric vehicle sector as…
-

Dow Jones, S&P, Nasdaq, U.S. Stocks May Lack Direction Following Disappointing Private Sector Jobs Data
The major U.S. index futures on the Dow Jones, S&P and Nasdaq are currently pointing to a roughly flat open on Wednesday, with stocks likely to show a lack of direction following the upward move seen over the two previous sessions. The futures had been pointing to a higher open on Wall Street but gave…
-

Hewlett Packard Enterprise Shares Surge Following Strong Q2 Results and Raised Outlook
Shares of Hewlett Packard Enterprise (NYSE:HPE) climbed over 6% in early premarket trading Wednesday after the company reported better-than-expected second-quarter earnings and delivered an optimistic outlook, supported by solid performance across its core business segments. HPE posted adjusted earnings per share of $0.38, surpassing the $0.32 consensus estimate, while revenue rose 6% year-over-year to $7.63…
-

Tesla Could Be a Key Player in Drone and eVTOL Market, Says Morgan Stanley
Morgan Stanley sees potential for Tesla (NASDAQ:TSLA) to emerge as a major force in the drone and electric vertical takeoff and landing (eVTOL) sectors—an area the bank believes could balloon into a $9 trillion total addressable market by 2050. In a research note sparked by a recent drone strike on Russian airfields during the Ukraine…
-

Dollar Tree Beats Sales Estimates Amid Tariff Concerns, Holds Full-Year Guidance
Dollar Tree (NASDAQ:DLTR) delivered better-than-expected sales for its fiscal first quarter as budget-conscious shoppers turned to the discount chain amid ongoing uncertainty tied to tariffs. However, unlike competitor Dollar General (NYSE:DG), the company opted not to revise its full-year revenue forecast upward. Net sales climbed 11.3% year-over-year to reach $4.6 billion, surpassing Bloomberg’s consensus forecast…
-

Thor Industries Stock Rallies as Q3 Earnings and Revenue Beat Estimates
Shares of Thor Industries Inc. (NYSE:THO) jumped 9.2% in early trading on Wednesday after the recreational vehicle giant delivered stronger-than-expected results for its fiscal third quarter. For the quarter ending April 30, the company reported adjusted earnings of $2.53 per share, well ahead of Wall Street’s estimate of $1.76. Revenue also came in above expectations,…
-

Microsoft Launches Free Cybersecurity Support for European Governments Amid Rising AI Threats
Microsoft (NASDAQ:MSFT) has unveiled a new cybersecurity initiative aimed at fortifying the digital defenses of European governments. Announced Wednesday, the program will be provided at no cost and is designed to help public institutions better withstand the evolving threat landscape, including attacks enhanced by artificial intelligence (AI). Brad Smith, Microsoft’s president, said the company plans…
-

Redwire Stock Gains After NASA Backs Lunar Construction Tech
Redwire Corporation (NYSE:RDW) saw its shares rise 5% after announcing a significant advancement in its extraterrestrial construction initiative. The company’s innovative Mason technology received the green light from NASA to move forward following a successful Critical Design Review (CDR), marking a major step toward developing infrastructure on the Moon and Mars. Mason is a specialized…
-

Sagimet Biosciences Shares Surge After Promising Phase 3 Acne Drug Results
Sagimet Biosciences Inc. (NASDAQ:SGMT) saw its stock soar 20% after unveiling encouraging Phase 3 trial results for its acne treatment candidate, denifanstat. The trial, conducted in China by its partner Ascletis Bioscience Co. Ltd., achieved all primary and secondary endpoints, boosting market confidence in the company’s innovative dermatology pipeline. Denifanstat, a once-daily oral inhibitor of…
-

REV Group Shares Rise on Strong Q2 Earnings and Upgraded 2025 Forecast
REV Group, Inc. (NYSE:REVG) delivered solid second-quarter results on Wednesday, beating Wall Street estimates and lifting its full-year outlook – sending its stock up 2.47% in premarket trading. The manufacturer of specialty vehicles posted adjusted earnings of $0.70 per share, outperforming analyst expectations of $0.55. Quarterly revenue climbed 2% year-over-year to $629.1 million, comfortably above…